Show simple item record

dc.contributor.authorAydemir, Emre
dc.contributor.authorBayat, Alper Halil
dc.contributor.authorÖren, Burak
dc.contributor.authorAteşoğlu, Halil İbrahim
dc.contributor.authorGöker, Yasin Şakir
dc.contributor.authorÖzçelik, Kazım Çağlar
dc.date.accessioned2021-09-06T11:32:02Z
dc.date.available2021-09-06T11:32:02Z
dc.date.issued2021en_US
dc.identifier.citationAydemir, E., Bayat, A. H., Ören, B., Ateşoğlu, H. İ., Göker, Y. Ş. ve Özçelik, K. Ç. (2021). Retinal vascular findings in patients with COVID-19. Therapeutic Advances in Ophthalmology, 13. https://dx.doi.org/10.1177/25158414211030419en_US
dc.identifier.issn2515-8414
dc.identifier.urihttps://dx.doi.org/10.1177/25158414211030419
dc.identifier.urihttps://hdl.handle.net/20.500.12511/8009
dc.description.abstractPurpose: The purpose of this study was to compare the retinal vascular caliber of COVID-19 patients with that of healthy subjects. Methods: This was a prospective case-control study. Forty-six patients who had COVID-19 were successfully treated, and 38 age- and gender-matched healthy subjects were enrolled in this study. Fundus photography was taken using fundus fluorescein angiography (FA; Visucam 500; Carl Zeiss Meditec, Jena, Germany). Retinal vascular caliber was analyzed with IVAN, a semi-automated retinal vascular analyzer (Nicole J. Ferrier, College of Engineering, Fundus Photography Reading Center, University of Wisconsin, Madison, WI, USA). Central retinal artery equivalent (CRAE), central retinal vein equivalent (CRVE), and artery-vein ratio (AVR) were compared between groups. Results: The mean age was 37.8 +/- 9.5 years in the COVID-19 group (n = 46) and 40 +/- 8 years in the control group (n = 38) (p = 0.45). The mean CRAE was 181.56 +/- 6.40 in the COVID-19 group and 171.29 +/- 15.06 in the control group (p = 0.006). The mean CRVE was 226.34 +/- 23.83 in the COVID-19 group and 210.94 +/- 22.22 in the control group (p = 0.044). AVR was 0.81 +/- 0.09 in the COVID-19 group and 0.82 +/- 0.13 in the control group (p = 0.712). Conclusion: Patients who had COVID-19 have vasodilation in the retinal vascular structure after recovery. As they may be at risk of retinal vascular disease, COVID-19 patients must be followed after recovery.en_US
dc.language.isoengen_US
dc.publisherSAGE Publications Ltden_US
dc.rightsinfo:eu-repo/semantics/openAccessen_US
dc.rightsAttribution-NonCommercial 4.0 International*
dc.rights.urihttps://creativecommons.org/licenses/by-nc/4.0/*
dc.subjectCOVID-19en_US
dc.subjectRetinal Vascular Caliberen_US
dc.subjectRetinal Vasodilationen_US
dc.titleRetinal vascular findings in patients with COVID-19en_US
dc.typearticleen_US
dc.relation.journalTherapeutic Advances in Ophthalmologyen_US
dc.departmentİstanbul Medipol Üniversitesi, Tıp Fakültesi, Cerrahi Tıp Bilimleri Bölümü, Göz Hastalıkları Ana Bilim Dalıen_US
dc.authorid0000-0003-1827-968Xen_US
dc.identifier.volume13en_US
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanıen_US
dc.identifier.doi10.1177/25158414211030419en_US


Files in this item

Thumbnail

This item appears in the following Collection(s)

Show simple item record

info:eu-repo/semantics/openAccess
Except where otherwise noted, this item's license is described as info:eu-repo/semantics/openAccess